Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Axsome Therapeutics (AXSM) Depreciation and Depletion (2022 - 2026)

Axsome Therapeutics' Depreciation and Depletion history spans 5 years, with the latest figure at $116000.0 for Q1 2026.

  • On a quarterly basis, Depreciation and Depletion fell 22.15% to $116000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $470000.0, a 14.39% decrease, with the full-year FY2025 number at $503000.0, down 5.45% from a year prior.
  • Depreciation and Depletion hit $116000.0 in Q1 2026 for Axsome Therapeutics, up from $114000.0 in the prior quarter.
  • Over the last five years, Depreciation and Depletion for AXSM hit a ceiling of $149000.0 in Q1 2025 and a floor of $37000.0 in Q1 2022.
  • Historically, Depreciation and Depletion has averaged $110176.5 across 5 years, with a median of $120000.0 in 2025.
  • Biggest five-year swings in Depreciation and Depletion: surged 143.24% in 2023 and later dropped 22.15% in 2026.
  • Tracing AXSM's Depreciation and Depletion over 5 years: stood at $85000.0 in 2022, then skyrocketed by 56.47% to $133000.0 in 2023, then fell by 3.01% to $129000.0 in 2024, then decreased by 11.63% to $114000.0 in 2025, then grew by 1.75% to $116000.0 in 2026.
  • Business Quant data shows Depreciation and Depletion for AXSM at $116000.0 in Q1 2026, $114000.0 in Q4 2025, and $120000.0 in Q3 2025.